🎉 Limited Time: Get 20% OFF + Free Shipping on Orders Over £50
Four Molecules. One Mission — Redefine Human Potential
From the clinically established GLP-1 analogue Semaglutide to the multi-pathway innovation Bioglutide, our compounds form the foundation of next-generation metabolic research.Each molecule is precision-engineered for laboratory use and molecular consistency — ensuring reproducibility, purity, and traceability across every batch.
Semaglutide –
The GLP-1 Benchmark
Function:
GLP-1 receptor agonist that improves appetite control, stabilizes glucose metabolism, and supports sustainable fat reduction.
Focus:
The foundational compound in metabolic research, Semaglutide delivers consistent appetite suppression, improved glycemic control, and measurable changes in body composition.
Key Attributes:
- Proven clinical performance reference compound.
- Mimics natural incretin responses.
- High molecular stability and predictable results.
Tirzepatide–
The Dual Receptor Powerhouse
Function:
Dual GIP and GLP-1 receptor agonist designed to enhance both insulin response and fat metabolism.
Focus:
Combines the appetite suppression of GLP-1 with the metabolic efficiency of GIP pathways, driving superior results in laboratory fat-loss studies.
Note:
Equivalent generic compounds available offering identical efficacy at reduced cost.
Key Attributes:
- Dual receptor activation for multi-pathway synergy.
- Promotes glucose optimization and adipose reduction.
- Benchmark for next-generation incretin research.
Retatrutide–
Triple Pathway Advancement
Function:
Triple receptor agonist activating GIP, GLP-1, and Glucagon pathways — currently under R&D investigation.
Focus:
Demonstrates unprecedented results in early research phases, combining multi-pathway fat oxidation, appetite regulation, and glucose balance.
Key Attributes:
- Multi-agonist hormone mimicry.
- Accelerated fat oxidation and energy expenditure.
- Potential breakthrough in metabolic efficiency.
Explore the Core Peptide Pathways
Skinny Jabs’ compounds operate across different receptor pathways — GLP-1, GIP, Glucagon, and IGF — each targeting distinct metabolic functions.
This quadrant structure allows researchers to identify and compare mechanisms driving appetite regulation, insulin sensitivity, and lean mass preservation.
